A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma (NCT06057948)
Phase II Trial of a Bivalent Vaccine With the Immunological Adjuvant OPT-821 (QS-21), in Combination With Randomization of Oral ฮฒ-glucan, for High-Risk Neuroblastoma
๐ฉบ Plain-English Summary (8th-Grade Level)
The purpose of this study is to test which treatment schedule of ฮฒ-glucan with bivalent vaccine is more effective for participants with high-risk neuroblastoma that is in complete remission.
Who can join: Review the eligibility criteria below.
Location: Memorial Sloan Kettering at Basking Ridge (Consent only) โ Basking Ridge, New Jersey
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (7 Sites)
- Memorial Sloan Kettering at Basking Ridge (Consent only) โ Basking Ridge, New Jersey
- Memorial Sloan Kettering Monmouth (Consent Only) โ Middletown, New Jersey
- Memorial Sloan Kettering Bergen (Consent Only) โ Montvale, New Jersey
- Memorial Sloan Kettering Suffolk-Commack (Consent only) โ Commack, New York
- Memorial Sloan Kettering Westchester (Consent only) โ Harrison, New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) โ New York, New York
- Memorial Sloan Kettering Nassau (Consent Only) โ Uniondale, New York
๐ Contact the Study Coordinator
Phone: (833) 675-5491
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Neuroblastoma
- Open-Label Study of 18F-mFBG for Imaging Neuroblastoma โ Los Angeles, California
- Neuroblastoma Precision Trial โ Los Angeles, California
- Neuroblastoma Maintenance Therapy Trial โ Birmingham, Alabama
- Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow โ Indianapolis, Indiana
- A Study of N9 Chemotherapy in Children With Neuroblastoma โ New York, New York
- A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma โ San Francisco, California
Explore by condition: All Neuroblastoma clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.